Mira Pharmaceuticals, Inc. (MIRA)

CIK 1904286 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mira Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Oct 28, 20268-K0001493152-26-048978
Oct 22, 20268-K0001493152-26-048022
Sep 17, 20268-K0001493152-26-043051
Sep 16, 20268-K0001493152-26-042927
Sep 1, 20268-K0001493152-26-040930
Aug 12, 202610-Q0001493152-26-037366
Aug 6, 20268-K0001493152-26-036262
Jul 31, 20268-K0001493152-26-035665
Jul 28, 2026DEF 14A0001493152-26-035027
Jul 10, 20268-K0001493152-26-032777
Jul 6, 20268-K0001493152-26-032091
Jun 25, 20268-K0001493152-26-030033
Jun 17, 20268-K0001493152-26-028992
Jun 15, 202640001493152-26-028715
Jun 15, 202640001493152-26-028712
Jun 15, 202640001493152-26-028713
Jun 15, 202640001493152-26-028714
Jun 9, 202630001493152-26-027959
Jun 8, 20268-K0001493152-26-027751
Jun 4, 20268-K0001493152-26-027202
May 27, 20268-K0001493152-26-025335
May 14, 202610-Q0001493152-26-023005
May 13, 20268-K0001493152-26-022704
May 13, 20268-K0001493152-26-022608
Apr 1, 202640001493152-26-014697